Epidemiological Study to Describe Non-small-cell Lung Carcinoma (NSCLC) Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA

Clinical trial NCT01330862 · UNKNOWN

Trial details

NCT number: NCT01330862
Sponsor: AstraZeneca
Status: UNKNOWN
Study type: OBSERVATIONAL

NSCLC Patient Characteristics

Start date: 2011-04-01
Primary completion: 2013-03-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.